How I treat postthrombotic syndrome.

Area of Science:

• Vascular Medicine
• Clinical Outcomes Research

Background:

• Postthrombotic syndrome (PTS) is a chronic complication following deep venous thrombosis (DVT), significantly impacting quality of life and incurring socioeconomic costs.
• PTS affects over one-third of DVT patients, with 5-10% developing severe forms, including venous ulceration.
• Key risk factors for PTS include persistent leg symptoms post-DVT, extensive or recurrent thrombosis, obesity, and advanced age.

Purpose of the Study:

• To review the current understanding of postthrombotic syndrome (PTS) following deep venous thrombosis (DVT).
• To discuss the role of elastic compression stockings (ECSs) in PTS prevention and management.
• To highlight areas for future research in PTS pathophysiology, risk factors, and treatment.

Main Methods:

• Systematic review of literature on postthrombotic syndrome (PTS) and deep venous thrombosis (DVT).
• Analysis of risk factors associated with PTS development.
• Evaluation of the efficacy and optimal use of compression therapy and pharmacologic interventions.

Main Results:

• Daily use of elastic compression stockings (ECSs) for two years post-proximal DVT may lower PTS risk.
• Uncertainty persists regarding the optimal duration, compression strength, and precise effect magnitude of ECSs.
• Venoactive medications like aescin and rutoside may offer temporary symptom relief for PTS.

Conclusions:

• The likelihood of developing PTS after DVT should be communicated to patients, with regular monitoring for symptoms and signs.
• Compression therapy with ECSs is the primary management strategy for PTS.
• Further research is crucial to understand PTS pathophysiology, identify risk factors, and develop improved preventive and therapeutic strategies to enhance long-term DVT patient outcomes.